XLV Holdings Information

XLV is an equity ETF with a total of 64 individual holdings. The top holdings are Eli Lilly and Company stock at 15.10%, Johnson & Johnson at 10.41%, AbbVie at 7.54%, Merck & Co. at 5.85%, and UnitedHealth Group at 5.38%.

Total Holdings

Top 10 Percentage

60.52%

Asset Class

Equity

ETF Category

Health

Assets

43.92B

PE Ratio

25.02

Top 25 Holdings

No.	Symbol	Name	% Weight	Shares
1	LLY	Eli Lilly and Company	15.10%	5,674,093
2	JNJ	Johnson & Johnson	10.41%	17,089,165
3	ABBV	AbbVie Inc.	7.54%	12,531,075
4	MRK	Merck & Co., Inc.	5.85%	17,495,302
5	UNH	UnitedHealth Group Incorporated	5.38%	6,365,035
6	TMO	Thermo Fisher Scientific Inc.	4.07%	2,621,951
7	AMGN	Amgen Inc.	3.72%	3,833,743
8	GILD	Gilead Sciences, Inc.	3.01%	8,792,724
9	ABT	Abbott Laboratories	2.79%	12,270,565
10	PFE	Pfizer Inc.	2.65%	40,417,697
11	ISRG	Intuitive Surgical, Inc.	2.34%	2,505,147
12	DHR	Danaher Corporation	2.26%	4,436,608
13	VRTX	Vertex Pharmaceuticals Incorporated	2.16%	1,797,300
14	BMY	Bristol-Myers Squibb Company	2.08%	14,485,394
15	MDT	Medtronic plc	1.80%	9,077,137
16	CVS	CVS Health Corporation	1.79%	9,069,471
17	MCK	McKesson Corporation	1.62%	826,816
18	SYK	Stryker Corporation	1.57%	2,475,182
19	ELV	Elevance Health, Inc.	1.38%	1,537,871
20	REGN	Regeneron Pharmaceuticals, Inc.	1.21%	695,183
21	CI	The Cigna Group	1.17%	1,873,745
22	MRNA	Moderna, Inc.	1.17%	2,632,919
23	BSX	Boston Scientific Corporation	1.03%	10,276,865
24	HCA	HCA Healthcare, Inc.	1.02%	1,043,974
25	COR	Cencora, Inc.	0.93%	1,353,183

Showing 25 of 64 holdings

Subscribe to see the full list

Activate Now

As of Oct 1, 2026